59
Views
1
CrossRef citations to date
0
Altmetric
Review

Potassium channel blockers as immunosuppressants

Pages 1209-1220 | Published online: 02 Dec 2005
 

Abstract

Recent advances in the biology of potassium channels have raised their profile as therapeutic targets for immunosuppression. Selective blockade of the intermediate-conductance calcium-activated potassium channel KCa3.1, and in particular, the voltage-gated potassium channel, Kv1.3 holds great promise in the modulation of different subsets of inflammatory T cells and B cells involved in the pathogenesis of autoimmune and inflammatory diseases. Relatively few selective blockers of these channels have been discovered to date, but this situation is likely to change as these channels become increasingly prominent as tractable and selective therapeutic targets, and especially if they are clinically validated as immunosuppressive targets.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.